We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors Likely to Impact DICK'S Sporting (DKS) Q1 Earnings
Read MoreHide Full Article
DICK’S Sporting Goods Inc. (DKS - Free Report) is expected to register year-over-year growth in both its top and the bottom-line performances when it releases first-quarter fiscal 2021 results on May 26. The Zacks Consensus Estimate for the quarterly earnings currently stands at 94 cents, which suggests a significant rebound from a loss of $1.21 a share incurred in the year-ago quarter. Moreover, the consensus mark has been revised 3 cents upward in the past seven days.
In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 10%. Further, it delivered an earnings surprise of 35.2%, on average, in the trailing four quarters.
Moreover, the consensus estimate for quarterly revenues is currently pegged at $2,160 million, indicating an improvement of about 62% from the year-ago quarter’s reported number.
Key Factors to Note
DICK’S Sporting is benefiting from favorable customer demand, a solid product portfolio and advanced omnichannel capabilities including curbside pickup services and BOPIS. Additionally, the company is witnessing a consistently strong in-store and online sales, which is likely to have continued to aid its top-line performance in the fiscal first quarter. Also, benefits from its collaboration with Instacart to offer same-day delivery service across its stores might have boosted its online sales.
Moreover, DICK’S Sporting’s consolidated same-store sales (comps) have been robust for a while on higher average ticket as well as strength in hardlines, apparel and footwear categories. On its last earnings call, management had noted that a strong business momentum will continue in fiscal 2021. Evidently, it predicted comps and the bottom line to increase year over year for the fiscal first quarter. Also, it anticipated the company’s team sports business to be a tailwind. Moreover, its golf business across both DICK'S and Golf Galaxy seems impressive.
While the aforesaid factors buoy optimism, the company continues to witness pandemic-related cost pressures. In fact, management envisioned COVID-related costs to the tune of $30 million for the first half of fiscal 2021.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for DICK’S Sporting this reporting cycle. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
DICK’S Sporting currently has a Zacks Rank #2 and an Earnings ESP of +17.59%.
More Stocks With Favorable Combination
Here are a few other companies worth considering from the same sector as our model shows that these too have the right combination of elements to beat on earnings:
Dollar General (DG - Free Report) presently has an Earnings ESP of +1.27% and a Zacks Rank #3.
Dollar Tree (DLTR - Free Report) has an Earnings ESP of +1.40% and a Zacks Rank of 3 at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Factors Likely to Impact DICK'S Sporting (DKS) Q1 Earnings
DICK’S Sporting Goods Inc. (DKS - Free Report) is expected to register year-over-year growth in both its top and the bottom-line performances when it releases first-quarter fiscal 2021 results on May 26. The Zacks Consensus Estimate for the quarterly earnings currently stands at 94 cents, which suggests a significant rebound from a loss of $1.21 a share incurred in the year-ago quarter. Moreover, the consensus mark has been revised 3 cents upward in the past seven days.
In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 10%. Further, it delivered an earnings surprise of 35.2%, on average, in the trailing four quarters.
Moreover, the consensus estimate for quarterly revenues is currently pegged at $2,160 million, indicating an improvement of about 62% from the year-ago quarter’s reported number.
Key Factors to Note
DICK’S Sporting is benefiting from favorable customer demand, a solid product portfolio and advanced omnichannel capabilities including curbside pickup services and BOPIS. Additionally, the company is witnessing a consistently strong in-store and online sales, which is likely to have continued to aid its top-line performance in the fiscal first quarter. Also, benefits from its collaboration with Instacart to offer same-day delivery service across its stores might have boosted its online sales.
Moreover, DICK’S Sporting’s consolidated same-store sales (comps) have been robust for a while on higher average ticket as well as strength in hardlines, apparel and footwear categories. On its last earnings call, management had noted that a strong business momentum will continue in fiscal 2021. Evidently, it predicted comps and the bottom line to increase year over year for the fiscal first quarter. Also, it anticipated the company’s team sports business to be a tailwind. Moreover, its golf business across both DICK'S and Golf Galaxy seems impressive.
While the aforesaid factors buoy optimism, the company continues to witness pandemic-related cost pressures. In fact, management envisioned COVID-related costs to the tune of $30 million for the first half of fiscal 2021.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for DICK’S Sporting this reporting cycle. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
DICKS Sporting Goods, Inc. Price and EPS Surprise
DICKS Sporting Goods, Inc. price-eps-surprise | DICKS Sporting Goods, Inc. Quote
DICK’S Sporting currently has a Zacks Rank #2 and an Earnings ESP of +17.59%.
More Stocks With Favorable Combination
Here are a few other companies worth considering from the same sector as our model shows that these too have the right combination of elements to beat on earnings:
Abercrombie & Fitch (ANF - Free Report) currently has an Earnings ESP of +43.82% and a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks heree.
Dollar General (DG - Free Report) presently has an Earnings ESP of +1.27% and a Zacks Rank #3.
Dollar Tree (DLTR - Free Report) has an Earnings ESP of +1.40% and a Zacks Rank of 3 at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>